Pulmatrix (PULM) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

PULM Pulmatrix

Watchlist

7.720
-0.420-5.16%

Close Feb 27 16:00 ET

7.750
+0.030+0.39%

Post 16:05 ET

28.20MMarket Cap-2.92P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Pulmatrix Shares Hit 52-Week High After News of Merger Deal
WSJNov 14, 2024 14:24 ET
Shareholder Alert: Ademi LLP Investigates Whether Pulmatrix, Inc. Is Obtaining a Fair Price for Its Public Shareholders
Business WireNov 13, 2024 21:53 ET
Pulmatrix PULM Cullgen Merger; Syros SYRS Phase 3 Data
BioPharmCatalystNov 13, 2024 15:40 ET
Sector Update: Health Care Stocks Edge Lower Wednesday Afternoon
MT NewswiresNov 13, 2024 13:53 ET
Pulmatrix Reaches Merger Agreement With Cullgen
MT NewswiresNov 13, 2024 11:19 ET
Cullgen to Absorb Pulmatrix, Join Nasdaq
WSJNov 13, 2024 09:26 ET

Comments

Jaguar8

Jan 22 07:02

NEWS

$Pulmatrix (PULM.US)$
Cullgen Begins Phase 1 Dosing of its Potential First-in-Class, Oral Pan-TRK Protein Degrader for Acute and Chronic Pain
Wednesday, 22nd January at 8:00 am
SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Cullgen Inc. ("Cullgen"), a privately-held, clinical-stage biopharmaceutical company applying its proprietary targeted protein degradation uSMITE™ platform to discover and advance therapeutics for the treatment of cancer and other diseases, today announced that it has begun...